Q: If you do not have any side effects and have been on semaglutide for two weeks at the 1.0 ml level, can you up it to 2.0 ml at week 3
Clinical trials show that approximately 14% of patients taking Wegovy experience headaches, compared to 10% on placebo
In the LEADER trial (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results), researchers found that liraglutide reduced the risk of cardiovascular events in diabetic patients, including heart attack, stroke, and cardiovascular death, by 13% compared to placebo
This step-by-step approach is critical for managing potential gastrointestinal side effects while maximizing the medications effectiveness
The treatment solution is CE marked, HSA Singapore registered, and specifically formulated to brighten the skin in sensitive areas